Search results
Is It Too Late to Buy Pfizer Stock?
The Motley Fool via AOL· 4 days agoAre Pfizer's (NYSE: PFE) best days behind it? If the stock's critics are to be believed, the answer is an emphatic "yes, obviously," with issues like its...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 6 days agoDespite a bevy of promising updates for its cancer treatments, Pfizer stock remains trapped below a...
Is It Too Late to Buy Pfizer Stock? | The Motley Fool
The Motley Fool· 4 days agoAre Pfizer's (PFE -0.43%) best days behind it? If the stock's critics are to be believed, the answer...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 21 hours agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed in state court in ...
Kansas Attorney General Kris Kobach sues Pfizer for COVID-19 vaccine
WIBW Topeka· 22 hours agoKansas Attorney General Kris Kobach on Monday morning announced he is suing Pfizer for what he said...
Pfizer setback brings questions for Duchenne gene therapy ahead of Sarepta decision
BioPharma Dive via Yahoo Finance· 5 days agoThe failure of another trial adds to uncertainty around the benefits of the gene-based treatments,...
Pfizer Failure in Duchenne Muscular Dystrophy Trial Leaves Field Open for a Rival
Barrons.com· 5 days agoPfizer disclosed on May 7 that a child participating in another...
Kansas Attorney General sues Pfizer for misleading covid claims
KOAM· 22 hours ago(KANSAS) -- Kansas Attorney General Kris Kobach is suing Pfizer for misleading claims made related...
Biotech startup raises $190 million to focus on new approach to heart attack, stroke and more - San...
The Business Journals· 4 hours agoA serial biotech entrepreneur, a longtime UCSF researcher, a shelved Big Pharma drug and $190...
Pfizer: An Oversold Pharma Stock in Recovery
GuruFocus.com via Yahoo Finance· 6 days agoSome say the art of investing is the ability of catching falling knives. Pfizer Inc. (NYSE:PFE) shares have sold off in 2023 and represent an attractive...